Crossover study of amlodipine versus nifedipine CR with home blood pressure monitoring via cellular phone: Internet-mediated open-label crossover trial of calcium channel blockers for hypertension (i-TECHO trial)

Journal of Hypertension

Volumn 25, Issue 11, 2007, Pages 2352-2358

  Ryuzaki, Munekazu ^a,g   Nakamoto, Hidetomo ^b   Nishida, Eiichi ^c   Sone, Masayoshi ^d   Nakajima, Sadao ^e   Yoshimoto, Mitsuo ^f   Suzuki, Yuka ^f   Itagaki, Kaori ^f  

^a Department of Nephrology   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c Department of Internal Medicine   (Japan)

^d Sone Clinic   (Japan)

^e Nakajima Clinic   (Japan)

^f Clinography Corporation   (Japan)

^g KAWASAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Amlodipine; Cellular phone; Home blood pressure; Morning blood pressure; Nifedipine CR; Telemedicine

Indexed keywords

AMLODIPINE; ATENOLOL; CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; DRUG INDUCED HEADACHE; FEMALE; HEART PALPITATION; HOME CARE; HUMAN; HYPERTENSION; INFORMATION PROCESSING; INTERNET PROTOCOL; MALE; MOBILE PHONE; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TELEMEDICINE;

EID: 35148870845     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282ef7adc     Document Type: Article

References (19)

1. Imai Y, Hozawa A, Ohkubo T, Tsuji I, Yamaguchi J, Matsubara M, et al. Predictive values of automated blood pressure measurement: what can we learn from the Japanese population? The Ohasama study. Blood Press Monit 2001; 6:335-339.
2. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of 'masked hypertension' detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291:1342-1349.
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
4. Whitworth JA. World Health Organization. International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21:1983-1992.
5. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
6. Japanese Society of Hypertension. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004). Hypertens Res 2006; Suppl: S1-S105.
7. Imai Y, Otsuka K, Kawano Y, Shimada K, Hayashi H, Tochikubo O, et al. Japanese Society of Hypertension: Japanese society of hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res 2003; 26:771-782.
8. Marquez-Contreras E, Martell-Claros N, Gil-Guillen V, Figuera-VonWichmann M, Casado-Martinez J, Martin-de Pablos J, et al. Efficacy of therapeutic compliance in hypertension: the EAPACU-HTA study. J Hypertens 2006; 24:169-175.
9. Nakamoto H, Kawamoto A, Tanabe Y, Nakagawa Y, Nishida E, Akiba T, Suzuki H. Telemedicine system for CAPD patients by using cellular phone. Adv Perit Dial 2006; 19:124-129.
10. Nakamoto H, Hatta M, Tanaka A, Moriwaki K, Oohama K, Kagawa K, et al. Telemedicine system for home automated peritoneal dialysis. Adv Perit Dial 2000; 16:191-194.
11. Ichihashi H. Formulation of sustained-release nifedipine tablets (Adalat CR) based on coat-core technology with a hydrophilic matrix [in Japanese]. Membrane 2000; 25:60-66.
12. Assaad MAE, Topouchian JA, Asmar RG. Evaluation of two devices for self-measurement of blood pressure according to the international protocol: the Omron M5-I and the Omron 705IT. Blood Press Monit 2003; 8:127-133.
13. Ishii M, Matsuoka H, Iimura O, Yoshinaga K, Yagi S, Saruta T, et al. Clinical efficacy of BAY a 1040-OD (sustained-release nifedipine) in patients with essential hypertension: Multicenter open trials of monotherapy and combined therapy [in Japanese]. Jpn Pharmacol Ther 1997; 25:1839-1868.
14. Masuyama Y, Arita M, Iimura O, Yoshinaga K, Abe K, Inagaki Y, et al. A multicenter trial of amlodipine besilate in patients with essential hypertension [in Japanese]. Jpn Pharmacol Ther 1991; 19:2853-2871.
15. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107:1401-1406.
16. Gosse P, Lasserre R, Minifie C, Lemetayer P, Clementy J. Blood pressure surge on rising. J Hypertens 2004; 22:1113-1118.
17. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, et al. Prognostic significance for stroke of a morning pressure surge and a nocturnal blood pressure decline: The Ohasama Study. Hypertension 2006; 47:149-154.
18. Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: The Framingham Study. Am Heart J 1993; 125:1148-1154.
19. Palatini P, Thijs L, Staessen JA, Fagard RH, Bulpitt CJ, Clement DL, et al. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002; 162:2313-2321.